Customer Service | Help | FAQ | PEP-Easy | Report a Data Error | About
:
Login
Tip: To print an article…

PEP-Web Tip of the Day

To print an article, click on the small Printer Icon located at the top right corner of the page, or by pressing Ctrl + P. Remember, PEP-Web content is copyright.

For the complete list of tips, see PEP-Web Tips on the PEP-Web support page.

Rivera, F.B. (2016). The Relevance of Arieti's Work in the Age of Medication. Am. J. Psychoanal., 76(3):266-280.
  

(2016). American Journal of Psychoanalysis, 76(3):266-280

The Relevance of Arieti's Work in the Age of Medication

Francisco Balbuena Rivera, Ph.D.

This paper looks at the relevance of psychoanalysis as a treatment option for psychotic individuals at a time when psychosis is invariably considered to be a biologically-based brain disease, for which the preferred course of treatment is psychotropic medication. In recent years, the use of psychoanalysis has declined noticeably in favor of evidenced-based biomedical approaches, which rely heavily upon statistical probabilities for ameliorating specific psychotic symptoms. Well-publicized biological approaches have proliferated, often to the detriment of the psychotic individual's general health, emotional recovery, and long-term rehabilitation. Sadly, these approaches may also be a significant factor affecting mortality rates in those suffering with psychosis, known to be about 25 years shorter, on average, than the general population.

[This is a summary excerpt from the full text of the journal article. The full text of the document is available to journal subscribers on the publisher's website here.]

Copyright © 2019, Psychoanalytic Electronic Publishing, ISSN 2472-6982 Customer Service | Help | FAQ | Download PEP Bibliography | Report a Data Error | About

WARNING! This text is printed for personal use. It is copyright to the journal in which it originally appeared. It is illegal to redistribute it in any form.